• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

透视时间作为经导管主动脉瓣置换术后短期预后的新预测指标

Fluoroscopy Time as a New Predictor of Short-Term Outcomes after Transcatheter Aortic Valve Replacement.

作者信息

Cafaro Alessandro, Spione Francesco, Burattini Osvaldo, De Feo Daniele, Xhelo Alessandro, Palmitessa Chiara, D'Alessandro Maurizio, Amendola Vincenzo Pio, Rimmaudo Flavio, Guaricci Andrea Igoren, Bortone Alessandro Santo, Pestrichella Vincenzo, Contegiacomo Gaetano, Tesorio Tullio, Colonna Giuseppe, Iacovelli Fortunato

机构信息

Division of Cardiology, "V. Fazzi" Hospital, 73100 Lecce, Italy.

Interventional Cardiology Service, "Montevergine" Clinic, GVM Care & Research, 83013 Mercogliano, Italy.

出版信息

J Cardiovasc Dev Dis. 2023 Nov 13;10(11):459. doi: 10.3390/jcdd10110459.

DOI:10.3390/jcdd10110459
PMID:37998517
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10671838/
Abstract

BACKGROUND

Transcatheter aortic valve replacement (TAVR) is an almost totally cine-fluoroscopic guided procedure. The amount of radiation used during the procedure is strictly related to the fluoroscopy time (FT), that has already been demonstrated to be associated with outcomes and complexity of coronary procedures. The aim of our study is to demonstrate the relationship between FT and the short-term outcomes after TAVR defined by to the Valve Academic Research Consortium (VARC)-2 and -3 consensus documents.

METHODS

After splitting 1797 consecutive patients into tertiles of FT, the composite endpoint early safety (ES) was adjudicated according to VARC-2 and VARC-3 definitions, whereas the composite endpoints device success (DS) and technical success (TS) according to VARC-3 criteria.

RESULTS

The absence of all these outcomes (VARC-2 ES amd VARC-3 TS, DS, and ES) was significantly associated with longer FT: this association was independent from both intraprocedural complications and other intraprocedural factors linked to longer FT, and still persisted after propensity score matching analysis. Notwithstanding, after receiver operating characteristic analysis, FT had adequate diagnostic accuracy in identifying the absence of only VARC-3 TS and VARC-2 ES.

CONCLUSION

Longer FT is related with periprocedural and short-term outcomes after the procedure, especially in those that are more challenging. A FT duration of more than 30 min has an adequate accuracy in identifying VARC-3 technical failure (TS and DS) and absence of VARC-2 ES, selecting patients who are likely to take advantage from more careful in-hospital follow-up.

摘要

背景

经导管主动脉瓣置换术(TAVR)几乎完全是在荧光透视引导下进行的手术。手术过程中使用的辐射量与透视时间(FT)密切相关,已有研究表明透视时间与冠状动脉手术的结果和复杂性相关。我们研究的目的是证明FT与经导管主动脉瓣置换术后由瓣膜学术研究联盟(VARC)-2和-3共识文件定义的短期结果之间的关系。

方法

将1797例连续患者按FT三分位数分组后,根据VARC-2和VARC-3定义判定复合终点早期安全性(ES),而根据VARC-3标准判定复合终点器械成功(DS)和技术成功(TS)。

结果

所有这些结果(VARC-2 ES以及VARC-3 TS、DS和ES)的缺失与更长的FT显著相关:这种关联独立于术中并发症以及与更长FT相关的其他术中因素,并且在倾向评分匹配分析后仍然存在。尽管如此,经过接受者操作特征分析,FT在识别仅VARC-3 TS和VARC-2 ES缺失方面具有足够的诊断准确性。

结论

更长的FT与术后围手术期和短期结果相关,尤其是在那些更具挑战性的手术中。FT持续时间超过30分钟在识别VARC-3技术失败(TS和DS)以及VARC-2 ES缺失方面具有足够的准确性,可筛选出可能受益于更仔细的院内随访的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7af4/10671838/b7c937394586/jcdd-10-00459-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7af4/10671838/c4864392cda4/jcdd-10-00459-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7af4/10671838/b7c937394586/jcdd-10-00459-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7af4/10671838/c4864392cda4/jcdd-10-00459-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7af4/10671838/b7c937394586/jcdd-10-00459-g002.jpg

相似文献

1
Fluoroscopy Time as a New Predictor of Short-Term Outcomes after Transcatheter Aortic Valve Replacement.透视时间作为经导管主动脉瓣置换术后短期预后的新预测指标
J Cardiovasc Dev Dis. 2023 Nov 13;10(11):459. doi: 10.3390/jcdd10110459.
2
Surgical Mortality Risk Scores in Transcatheter Aortic Valve Implantation: Is Their Early Predictive Value Still Strong?经导管主动脉瓣植入术中的手术死亡风险评分:其早期预测价值是否依然强大?
J Cardiovasc Dev Dis. 2023 May 31;10(6):244. doi: 10.3390/jcdd10060244.
3
1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry.经导管主动脉瓣置换术后女性 1 年的临床结局:来自首个 WIN-TAVI 注册研究的结果。
JACC Cardiovasc Interv. 2018 Jan 8;11(1):1-12. doi: 10.1016/j.jcin.2017.09.034.
4
Transcatheter Aortic Valve Replacement With Next-Generation Self-Expanding Devices: A Multicenter, Retrospective, Propensity-Matched Comparison of Evolut PRO Versus Acurate neo Transcatheter Heart Valves.经导管主动脉瓣置换术联合新一代自膨式瓣膜:Evolut PRO 与 Acurate neo 经导管心脏瓣膜多中心、回顾性、倾向性匹配比较研究。
JACC Cardiovasc Interv. 2019 Mar 11;12(5):433-443. doi: 10.1016/j.jcin.2018.11.036.
5
Validation of the VARC-3 Technical Success Definition in Patients Undergoing TAVR.经导管主动脉瓣置换术患者中 VARC-3 技术成功定义的验证。
JACC Cardiovasc Interv. 2022 Feb 28;15(4):353-364. doi: 10.1016/j.jcin.2021.11.013. Epub 2022 Jan 31.
6
Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Balloon-Expandable Transcatheter Heart Valve: A Single-Center Experience.经导管主动脉瓣置换术使用新型球囊扩张式经导管心脏瓣膜的结果:单中心经验。
JACC Cardiovasc Interv. 2015 Dec 21;8(14):1809-16. doi: 10.1016/j.jcin.2015.08.014.
7
Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry.经导管主动脉瓣置换术(TAVR)后女性的急性和 30 天结局:来自 WIN-TAVI(女性国际经导管主动脉瓣植入)真实世界注册研究的结果。
JACC Cardiovasc Interv. 2016 Aug 8;9(15):1589-600. doi: 10.1016/j.jcin.2016.05.015.
8
Incidence, Predictors, and Prognostic Impact of Bleeding Events After TAVR According to VARC-3 Criteria.根据 VARC-3 标准,TAVR 后出血事件的发生率、预测因素和预后影响。
JACC Cardiovasc Interv. 2023 Sep 25;16(18):2262-2274. doi: 10.1016/j.jcin.2023.07.005. Epub 2023 Sep 6.
9
Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies.经 Valve Academic Research Consortium 定义的经导管主动脉瓣置换术后的临床结局:来自 16 项研究的 3519 例患者的加权荟萃分析。
J Am Coll Cardiol. 2012 Jun 19;59(25):2317-26. doi: 10.1016/j.jacc.2012.02.022. Epub 2012 Apr 11.
10
Performance and short-term outcomes of three different transcatheter aortic valve replacement devices in patients with aortic stenosis: A single-center experience.三种不同经导管主动脉瓣置换装置在主动脉瓣狭窄患者中的应用效果和短期预后:单中心经验。
J Chin Med Assoc. 2019 Nov;82(11):827-834. doi: 10.1097/JCMA.0000000000000187.

引用本文的文献

1
Evaluating the Impacts of Procedural and Patient-Specific Factors on the Outcomes of Transcatheter Aortic Valve Implantation (TAVI).评估手术及患者特异性因素对经导管主动脉瓣植入术(TAVI)结局的影响。
Medicina (Kaunas). 2025 Jan 9;61(1):94. doi: 10.3390/medicina61010094.

本文引用的文献

1
Surgical Mortality Risk Scores in Transcatheter Aortic Valve Implantation: Is Their Early Predictive Value Still Strong?经导管主动脉瓣植入术中的手术死亡风险评分:其早期预测价值是否依然强大?
J Cardiovasc Dev Dis. 2023 May 31;10(6):244. doi: 10.3390/jcdd10060244.
2
Vascular Access in Patients With Peripheral Arterial Disease Undergoing TAVR: The Hostile Registry.经导管主动脉瓣置换术患者外周动脉疾病血管通路:敌意登记。
JACC Cardiovasc Interv. 2023 Feb 27;16(4):396-411. doi: 10.1016/j.jcin.2022.12.009. Epub 2023 Jan 18.
3
CT in Transcatheter-delivered Treatment of Valvular Heart Disease.
CT 在经导管瓣膜心脏病治疗中的应用。
Radiology. 2022 Jul;304(1):4-17. doi: 10.1148/radiol.210567. Epub 2022 May 31.
4
Identifying Patients without a Survival Benefit following Transfemoral and Transapical Transcatheter Aortic Valve Replacement.经股动脉和经心尖经导管主动脉瓣置换术后无生存获益患者的识别
J Clin Med. 2021 Oct 24;10(21):4911. doi: 10.3390/jcm10214911.
5
Association of Prolonged Fluoroscopy Time with Procedural Success of Percutaneous Coronary Intervention for Stable Coronary Artery Disease with and without Chronic Total Occlusion.透视时间延长与伴或不伴慢性完全闭塞的稳定型冠状动脉疾病经皮冠状动脉介入治疗手术成功率的相关性
J Clin Med. 2021 Apr 3;10(7):1486. doi: 10.3390/jcm10071486.
6
Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research.瓣膜学术研究联合会 3 期:主动脉瓣临床研究更新的终点定义。
Eur Heart J. 2021 May 14;42(19):1825-1857. doi: 10.1093/eurheartj/ehaa799.
7
Clinical Factors Associated with Long Fluoroscopy Time in Percutaneous Coronary Interventions to the Culprit Lesion of Non-ST-Segment Elevation Myocardial Infarction.非 ST 段抬高型心肌梗死罪犯病变经皮冠状动脉介入治疗中与长时间透视时间相关的临床因素。
Int Heart J. 2021 Mar 30;62(2):282-289. doi: 10.1536/ihj.20-634. Epub 2021 Mar 17.
8
Evaluation of a Low-Dose Radiation Protocol During Transcatheter Aortic Valve Implantation.经导管主动脉瓣植入术中低剂量辐射方案的评估。
Am J Cardiol. 2021 Jan 15;139:71-78. doi: 10.1016/j.amjcard.2020.10.035. Epub 2020 Oct 24.
9
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients.经皮球囊扩张式主动脉瓣置换术治疗低危患者。
N Engl J Med. 2019 May 2;380(18):1695-1705. doi: 10.1056/NEJMoa1814052. Epub 2019 Mar 16.
10
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.经导管主动脉瓣置换术治疗低危患者的自膨式瓣膜。
N Engl J Med. 2019 May 2;380(18):1706-1715. doi: 10.1056/NEJMoa1816885. Epub 2019 Mar 16.